Genetic testing company 23andMe’s bankruptcy filing in March looked like a glum end to a short, troubled life. The stock had crashed from a peak of $320 in 2021 to less than $2 in March. Losses were mounting, and cash was running out fast.
基因檢測公司23andMe公司于今年3月申請破產，這似乎為其短暫而多舛的歷程畫上了黯淡的句號。該公司股價自2021年高點的320美元暴跌至今年3月的不足2美元。虧損不斷擴大，現金也迅速枯竭。
您已閱讀8%（334字），剩余92%（3614字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。